3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Nature Publishing Group
2022-03-01
|
| Saila: | Signal Transduction and Targeted Therapy |
| Sarrera elektronikoa: | https://doi.org/10.1038/s41392-022-00937-9 |